Kazuki Nakamura
Yamagata, 9909585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Clotrimazole Targets the c-Myc-Survivin Axis to Reduce the Viability of Ovarian Cancer Stem Cells Alone and in Combination with Chemotherapeutic Agents.
Journal: International journal of molecular sciences
Published: June 08, 2026
Endoscopic Hematoma Evacuation for Spontaneous Intracerebral Hemorrhage: A Single-Center Retrospective Analysis of 136 Consecutive Cases.
Journal: World neurosurgery
Published: June 01, 2026
Prognostic impact of RANO resect group classification post-chemoradiotherapy in IDH-wildtype glioblastoma.
Journal: Journal of neuro-oncology
Published: June 01, 2026
Efficient Inhibition of FOXM1 Expression and Viability of High-grade Meningioma Cells by Domatinostat-mediated Dual Targeting of HDAC1 and HDAC2.
Journal: Anticancer research
Published: July 28, 2025
HDAC Class I Inhibitor Domatinostat Induces Apoptosis Preferentially in Glioma Stem Cells Through p53-Dependent and -Independent Activation of BAX Expression.
Journal: International journal of molecular sciences
Published: July 03, 2025
The MDM4 Inhibitor CEP-1347 Activates Wild-type p53 in Ovarian Clear Cell Carcinoma Cells and Potently Inhibits their Growth.
Journal: Anticancer research
Published: June 26, 2025
Targeting Bcl-xL with Navitoclax Effectively Eliminates Senescent Tumor Cells That Appear Following CEP-1347-Induced Differentiation of Glioma Stem Cells.
Journal: International journal of molecular sciences
Published: June 09, 2025
Effective Targeting of Glioma Stem Cells by BSJ-04-122, a Novel Covalent MKK4/7 Dual Inhibitor.
Journal: Anticancer research
Published: May 26, 2025
Extracranial Thrombosed Vertebral Aneurysm Associated Neurofibromatosis Type1 Treated by Neuroendovascular Coil Embolization: A Case Report and Review of Literature.
Journal: Clinical case reports
Published: September 18, 2024
CEP-1347 Boosts Chk2-Mediated p53 Activation by Ionizing Radiation to Inhibit the Growth of Malignant Brain Tumor Cells.
Journal: International journal of molecular sciences
Published: July 12, 2024
The MDM2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells.
Journal: International journal of molecular sciences
Published: February 19, 2024
Last Updated: 09/26/2026